EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Successful topical simvastatin therapy in a 2-year-old girl with keratin 16-associated palmoplantar epidermal differentiation disorder

Qingmei Zhong, Ying Zhang, Zhen Feng, Jinyan Zhang, Borui Chen

Frontiers in Pediatrics · 02.07.2026 · 14

DOI: 10.3389/fped.2026.1891570 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 02.07.2026. Verfasst von Qingmei Zhong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Dermatology Hospital of Fuzhou First General Hospital, Fujian Medical University, Fuzhou, Fujian, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Palmoplantar epidermal differentiation disorder associated with pachyonychia congenita is a rare autosomal dominant genodermatosis characterized by painful palmoplantar hyperkeratosis and nail dystrophy. Treatment options remain limited, particularly in young children, in whom systemic therapies carry safety concerns. Herein, we report a 2-year-old girl who presented with palmoplantar hyperkeratosis since 1 month of age, with progressive nail dystrophy involving all 20 nails. Whole-exome sequencing identified a hemizygous multi-exon deletion in keratin 16 (ClinVar: SUB16259296; OMIM: #167200), and orthogonal validation using amplicon-based high-throughput sequencing confirmed a 437-nucleotide deletion predicted to result in a frameshift with premature termination codon (PTC). American College of Medical Genetics and Genomics classification supported likely pathogenicity. Twice-daily application of topical 2.5% simvastatin/cholesterol cream for 11 weeks produced substantial improvement in plantar hyperkeratosis, resolution of painful fissures, and visibly improved morphology of nascent nail growth. No local or systemic adverse effects were observed. This case provides preliminary evidence that topical simvastatin may be an effective and well-tolerated therapy for keratin 16-associated palmoplantar epidermal differentiation disorder in young children, and highlights the potential importance of topical drug delivery in achieving therapeutic efficacy for this genetic subtype.

Schlagwörter

Stichwörter der Autor:innen

keratin 16pachyonychia congenitapalmoplantar epidermal differentiation disorderpediatricsimvastatintopical therapy

Autor:innen und Institutionen

  • Department of Dermatology, Dermatology Hospital of Fuzhou First General Hospital, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Dermatology, Fujian Provincial Geriatric Hospital, Fuzhou, Fujian, China.

Zitieren

APA

Zhong, Q., Zhang, Y., Feng, Z., Zhang, J., & Chen, B. (2026). Case Report: Successful topical simvastatin therapy in a 2-year-old girl with keratin 16-associated palmoplantar epidermal differentiation disorder. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1891570

Vancouver

Zhong Q, Zhang Y, Feng Z, Zhang J, Chen B. Case Report: Successful topical simvastatin therapy in a 2-year-old girl with keratin 16-associated palmoplantar epidermal differentiation disorder. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1891570

BibTeX
@article{Zhong2026,
  author = {Zhong, Qingmei and Zhang, Ying and Feng, Zhen and Zhang, Jinyan and Chen, Borui},
  title = {Case Report: Successful topical simvastatin therapy in a 2-year-old girl with keratin 16-associated palmoplantar epidermal differentiation disorder},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1891570}
}
Kostenlos starten →